The WACC of Sorrento Therapeutics Inc (SRNE) is 7.6%.
| Range | Selected | |
| Cost of equity | 253.00% - 461.70% | 357.35% |
| Tax rate | 0.60% - 1.60% | 1.10% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 5.5% - 9.7% | 7.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 54.16 | 81.58 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 253.00% | 461.70% |
| Tax rate | 0.60% | 1.60% |
| Debt/Equity ratio | 160.53 | 160.53 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 5.5% | 9.7% |
| Selected WACC | 7.6% | |